Pretomanid is a nitroimidazooxazine antimycobacterial agent used in combination with other antituberculosis drugs in the treatment of multidrug resistant tuberculosis. The addition of pretomanid to antituberculosis drug regimens has been linked to an increased rate of transient serum liver test abnormalities during treatment and to several instances of mild, clinically apparent liver injury. Its therapeutic use is listed as anti-infectives, antibiotics and antituberculars. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6, 7-dihydro-5H-imidazo(2, 1-b)(1, 3)oxazine and pretomanidum. Its PubChem CID is 456199.
Pretomanid
| CAS No | 187235-37-6 |
|---|---|
| Molecular Formula | C14H12F3N3O5 |
| Molecular Weight | 359.26 g/mol |
| Synonyms | (6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pretomanid is a nitroimidazooxazine antimycobacterial agent used in combination with other antituberculosis drugs in the treatment of multidrug resistant tuberculosis.
The listed CAS number is 187235-37-6.
The listed molecular formula is C14H12F3N3O5.
The listed molecular weight is 359.26 g/mol.
(6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine.
The source lists 2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6, 7-dihydro-5H-imidazo(2, 1-b)(1, 3)oxazine and pretomanidum.